Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-26

FDA Approved: INVOKANA — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA has approved a supplemental application for INVOKANA (canagliflozin) submitted by Janssen Pharmaceuticals, Inc. The approval updates the product labelin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INVOKANA (CANAGLIFLOZIN)

Snippet

SUPPL AP for INVOKANA (CANAGLIFLOZIN)